Tyler Prize Mourns the Passing of Laureate Madhav Gadgil GlobeNewswire January 08, 2026 LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) — The Tyler Prize for Environmental Achievement today mourns the passing of Madhav Gadgil, a pioneering ecologist, public intellectual, and Tyler Prize Laureate. Prof. Gadgil was one of the most consequential environmental scientists and policy […]

(NYSE:GETY), A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today announced Access by Getty Images, a new offering developed in partnership with Greenfly, the leader in powering short-form content operations

Getty Images and Greenfly Launch Access by Getty Images, Giving Talent Real-Time, Licensed Access to Red Carpet and Events Coverage for Social Media First-of-its-kind solution to deliver instant access to top-tier, credible entertainment imagery for personal social media needs of talent and industry professionals GlobeNewswire January 08, 2026 A Media Snippet accompanying this announcement is

(NASDAQ:IINN), RA'ANANA, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) — Inspira(TM) Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today outlines its strategic vision and proposed transaction framework for its planned expansion into liquid biopsy diagnostics, outlining a structured approach designed to preserve shareholder

Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion Company details contemplated transaction structure designed to preserve shareholder value and enable future dividend distributions from core technologies GlobeNewswire January 08, 2026 RA'ANANA, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) — Inspira(TM) Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the

(NASDAQ:BFRI),(NASDAQ:BFRIW), Database locks for studies on actinic keratosis (AK) and acne vulgaris achieved on January 5, 2026 Data generated will support key regulatory milestones for Ameluz PDT in both indications AK and acne are the two most commonly diagnosed skin disorders in the US1 WOBURN, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq:

(NASDAQ:PLRZ), As part of the branding process, Polyrizon conducted comprehensive trademark screening across the U.S. and European markets Raanana, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that it has completed the branding process for its

(Other OTC:ORBT),(OTC US:ORBT),(Pinksheets:ORBT),(PinkSheets:ORBT), HAUPPAUGE, N.Y., Jan. 08, 2026 (GLOBE NEWSWIRE) — Orbit International Corp. (the “Company”) (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for the month of December 2025 were approximately $3,400,000. This firm month of bookings for December helped push consolidated bookings for the fourth quarter

Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones GlobeNewswire January 08, 2026 Database locks for studies on actinic keratosis (AK) and acne vulgaris achieved on January 5, 2026 Data generated will support key regulatory milestones for Ameluz PDT in both indications AK and acne are the two

Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX(TM) GlobeNewswire January 08, 2026 As part of the branding process, Polyrizon conducted comprehensive trademark screening across the U.S. and European markets Raanana, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company